Results 11 to 20 of about 16,252 (181)
Asian Journal of Transfusion Science, 2013 Introduction: To study whether the administration of recombinant human erythropoietin increases the amount of autologous blood that can be collected before orthopaedic surgery.
Kumkum Sharma +4 more
doaj +1 more source
Effect of erythropoietin in treatment of renal anemia in a sample of Iraqi patient [PDF]
Al Ameen Journal of Medical Sciences, 2021 Background: Anemia is a common complication of chronic kidney disease and it is associated with a reduce in the quality of life of patients, it contributes an increase in morbidity and mortality and accelerates the rate of progression of chronic kidney ...
Ali J. Hashim Al Saedi +1 more
doaj
A lentiviral gene therapy strategy for the in vitro production of feline erythropoietin. [PDF]
PLoS ONE, 2012 Nonregenerative anemia due to chronic renal failure is a common problem in domestic cats. Unfortunately, administration of recombinant human erythropoietin often only improves anemia temporarily due to antibody development. In this in vitro study, feline
Natalia Vapniarsky +3 more
doaj +1 more source
Erythropoietin reduces storage lesions and decreases apoptosis indices in blood bank red blood cells
Revista Brasileira de Hematologia e Hemoterapia, 2016 Background: Recent evidence shows a selective destruction of the youngest circulating red blood cells (neocytolysis) trigged by a drop in erythropoietin levels.
Oscar Andrés Penuela +2 more
doaj +1 more source
Journal of Community Hospital Internal Medicine Perspectives, 2021 Background and objectives Anemia is a prevalent complication endured by patients with chronic renal disease. Renal anemia also leads to the development of cardio-vascular complications.
Muhammad Nadeem Ahsan +7 more
doaj +1 more source
Recombinant erythropoietin in clinical practice [PDF]
Postgraduate Medical Journal, 2003 Abstract The introduction of recombinant human erythropoietin (RHuEPO) has revolutionised the treatment of patients with anaemia of chronic renal disease. Clinical studies have demonstrated that RHuEPO is also useful in various non-uraemic conditions including haematological and oncological disorders, prematurity, HIV infection, and ...
T, Ng +3 more
openaire +2 more sources
Allergy, Asthma & Clinical Immunology, 2018 Background Recombinant human erythropoietin, such as epoetin alfa and darbepoetin alfa, is an important therapy for anemia due to chronic renal failure. Allergy to recombinant human erythropoietin and the need for desensitization are rare.
Jaime S. Rosa +3 more
doaj +1 more source
Effects of Recombinant Erythropoietin on Breast Cancer-Initiating Cells
Neoplasia: An International Journal for Oncology Research, 2007 BACKGROUND: Cancer anemia causes fatigue and correlates with poor treatment outcome. Erythropoietin has been introduced in an attempt to correct these defects.
Tiffany M. Phillips +4 more
doaj +1 more source
Anti-Erythropoietin Antibody Associated Pure Red Cell Aplasia Resolved after Liver Transplantation
Case Reports in Transplantation, 2015 Patients undergoing antiviral therapy for chronic hepatitis C often develop anemia secondary to ribavirin and interferon. Recombinant erythropoietin has been used to improve anemia associated with antiviral therapy and to minimize dose reductions, which ...
Annie K. Hung +3 more
doaj +1 more source
Macrophages as novel target cells for erythropoietin
Haematologica, 2010 Background Our original demonstration of immunomodulatory effects of erythropoietin in multiple myeloma led us to the search for the cells in the immune system that are direct targets for erythropoietin.
Lilach Lifshitz +4 more
doaj +1 more source